Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus

International Journal of Antimicrobial Agents

Volumn 45, Issue 5, 2015, Pages 477-484

  Ellington, Matthew J ^a,b   Reuter, Sandra ^b   Harris, Simon R ^b   Holden, Matthew T G ^b,f   Cartwright, Edward J ^c   Greaves, Daniel ^d   Gerver, Sarah M ^e   Hope, Russell ^e   Brown, Nicholas M ^a,d   Török, M Estee ^a,c,d   Parkhill, Julian ^b   Köser, Claudio U ^c   Peacock, Sharon J ^a,b,c,d  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antimicrobial resistance; CA MRSA; SCC genomics; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; FUSIDIC ACID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; DRUG UTILIZATION; FEMALE; GENETICS; GREAT BRITAIN; HUMAN; ISOLATION AND PURIFICATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EVOLUTION; PRESCHOOL CHILD; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; EVOLUTION, MOLECULAR; FEMALE; FUSIDIC ACID; GENES, BACTERIAL; GREAT BRITAIN; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84939983385     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.01.009     Document Type: Article

References (30)

1. S.K. Fridkin, J.C. Hageman, M. Morrison, L.T. Sanza, K. Como-Sabetti, and J.A. Jernigan et al. Methicillin-resistant Staphylococcus aureus disease in three communities N Engl J Med 352 2005 1436 1444
2. J.R. Mediavilla, L. Chen, B. Mathema, and B.N. Kreiswirth Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) Curr Opin Microbiol 15 2012 588 595
3. J.L. Wang, H.J. Tang, P.H. Hsieh, F.Y. Chiu, Y.H. Chen, and M.C. Chang et al. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus Int J Antimicrob Agents 40 2012 103 107
4. M. Castanheira, A.A. Watters, J.M. Bell, J.D. Turnidge, and R.N. Jones Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008 Antimicrob Agents Chemother 54 2010 3614 3617
5. M. Castanheira, A.A. Watters, R.E. Mendes, D.J. Farrell, and R.N. Jones Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008) J Antimicrob Chemother 65 2010 1353 1358
6. C.M. Chen, M. Huang, H.F. Chen, S.C. Ke, C.R. Li, and J.H. Wang et al. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital BMC Microbiol 11 2011 98
7. D.J. Farrell, M. Castanheira, and I. Chopra Characterization of global patterns and the genetics of fusidic acid resistance Clin Infect Dis 52 2011 S487 S492
8. D. Livermore, D. James, G. Duckworth, and P. Stephens Fusidic-acid use and resistance Lancet 360 2002 806
9. A. Pearson, A. Chronias, and M. Murray Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England J Antimicrob Chemother 64 2009 i11 i17
10. J.M. Andrews, R.A. Howe BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method (version 10) J Antimicrob Chemother 66 2011 2726 2757
11. C.U. Koser, M.T. Holden, M.J. Ellington, E.J. Cartwright, N.M. Brown, and A.L. Ogilvy-Stuart et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak N Engl J Med 366 2012 2267 2275
12. H. Ponstigl SMALT manual, version 0.3.2 2010 Wellcome Trust Sanger Institute
13. A. Stamatakis RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models Bioinformatics 22 2006 2688 2690
14. T. Carver, S.R. Harris, M. Berriman, J. Parkhill, and J.A. McQuillan Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data Bioinformatics 28 2012 464 469
15. F.J. Cooke, and N.M. Brown Community-associated methicillin-resistant Staphylococcus aureus infections Br Med Bull 94 2010 215 227
16. F.J. Cooke, E. Gkrania-Klotsas, J.C. Howard, M. Stone, A.M. Kearns, and M. Ganner et al. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia Clin Microbiol Infect 16 2010 921 926
17. G.W. Coombs, S. Monecke, J.C. Pearson, H.L. Tan, Y.K. Chew, and L. Wilson et al. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region BMC Microbiol 11 2011 215
18. W. Qi, M. Ender, F. O'Brien, A. Imhof, C. Ruef, and N. McCallum et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Zurich, Switzerland (2003): prevalence of type IV SCCmec and a new SCCmec element associated with isolates from intravenous drug users J Clin Microbiol 43 2005 5164 5170
19. J. Scerri, S. Monecke, and M.A. Borg Prevalence and characteristics of community carriage of methicillin-resistant Staphylococcus aureus in Malta J Epidemiol Glob Health 3 2013 165 173
20. A.C. Uhlemann, J. Dordel, J.R. Knox, K.E. Raven, J. Parkhill, and M.T. Holden et al. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community Proc Natl Acad Sci USA 111 2014 6738 6743
21. A.C. Shore, and D.C. Coleman Staphylococcal cassette chromosome mec: recent advances and new insights Int J Med Microbiol 303 2013 350 359
22. D.C. Holt, M.T. Holden, S.Y. Tong, S. Castillo-Ramirez, L. Clarke, and M.A. Quail et al. A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin Genome Biol Evol 3 2011 881 895
23. X.X. Ma, T. Ito, C. Tiensasitorn, M. Jamklang, P. Chongtrakool, and S. Boyle-Vavra et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains Antimicrob Agents Chemother 46 2002 1147 1152
24. M.T. Holden, E.J. Feil, J.A. Lindsay, S.J. Peacock, N.P. Day, and M.C. Enright et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance Proc Natl Acad Sci USA 101 2004 9786 9791
25. Y.T. Lin, J.C. Tsai, H.J. Chen, W.C. Hung, P.R. Hsueh, and L.J. Teng A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 58 2014 1224 1227
26. D.A. Williamson, S. Monecke, H. Heffernan, S.R. Ritchie, S.A. Roberts, and A. Upton et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale Clin Infect Dis 59 2014 1451 1454
27. D. Spelman Fusidic acid in skin and soft tissue infections Int J Antimicrob Agents 12 1999 S59 S66
28. L.J. Shallcross, I. Petersen, J. Rosenthal, A.M. Johnson, N. Freemantle, and A.C. Hayward Use of primary care data for detecting impetigo trends, United Kingdom, 1995-2010 Emerg Infect Dis 19 2013 1646 1648
29. Antibiotic resistance and topical treatment. Br Med J 1978; 2:649-50.
30. O. Sule, N.M. Brown, L.J. Willocks, J. Day, S. Shankar, and C.R. Palmer et al. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use Int J Antimicrob Agents 30 2007 78 82